Start Submission Become a Reviewer

Reading: Percutaneous ablation of malignant thoracic tumors


A- A+
Alt. Display

Original Article

Percutaneous ablation of malignant thoracic tumors


B Ghaye

Department of Radiology, Cliniques Universitaires St Luc, Catholic University of Louvain, Brussels, Belgium, BE
X close


Lung cancer is the leading cause of death related to cancer. Fifteen to thirty percent of patients with a localized lung cancer are actually inoperable as they present with poor general condition, limited cardiopulmonary function, or a too high surgical risk. Therefore, minimally invasive treatments are needed and percutaneous ablation seems an attractive option. Thermal ablation can be performed by delivering heat (radiofrequency, microwave, laser) or cold (cryotherapy) through a needle inserted into the tumor under CT guidance. The ideal lesion is less than 2 or 3 cm in diameter. Success of percutaneous thermal ablation appears to be close to those of surgery for localized lung cancer. Nevertheless studies are still needed to definitely assess the role of ablation compared to other emerging techniques, as stereotactic radiotherapy as well as potential synergy with other treatments.

How to Cite: Ghaye B. Percutaneous ablation of malignant thoracic tumors. JBR-BTR. 2013;96(3):142–54. DOI:
Published on 01 May 2013.
Peer Reviewed


  • PDF (EN)

    comments powered by Disqus